CD8A and neoplasm: The ECM-cluster with better prognosis usually exhibit fewer fibroblasts and tumor-promoting cells (such as M2 macrophages and Treg cells), as well as more tumor-killing cells (such as M1 macrophages, NK cells, CD8+ T cells and Th1 cells).